New FDA-approved ‘Wegovy HD’ offers triple the semaglutide dosage

New FDA-approved ‘Wegovy HD’ offers triple the semaglutide dosage

The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long-term weight loss maintenance for adult patients. It is triple the previous maximum dose of 2.4 mg. This marks the fourth approval in the FDA’s National … Read more

Semaglutide injections have surprising benefits for liver disease patients, study shows

Semaglutide injections have surprising benefits for liver disease patients, study shows

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide, which is traditionally a treatment for type 2 diabetes, was given to participants who had been diagnosed with a life-threatening form of liver disease called metabolic dysfunction associated steatohepatitis … Read more